LVAD Simulator: Accelerate the R&D Cycle of Artificial Hearts

LVAD Simulator: Accelerate the R&D Cycle of Artificial Hearts

​​
As one of the most sophisticated high-end medical devices, the research and development of Left Ventricular Assist Devices (LVADs) stands among the most challenging undertakings in the industry. Amid intensifying market competition, it has become critical to shorten lengthy R&D cycles and obtain credible test data recognized by regulatory authorities.

Core Pain Points in LVAD Development
Classified as high-risk Class III implantable medical devices, LVAD R&D teams are commonly confronted with three major challenges:
Difficult Simulation: How to replicate extreme physiological conditions such as heart failure and suction events in laboratory settings.
Limited Real-time Monitoring: Failure to track real-time changes of pressure-volume (P-V) loops after Simuheart Pump implantation.
Tough Regulatory Approval: NMPA and FDA impose stringent traceability requirements on in-vitro test data; inaccurate data will directly lead to application rejection.
Trandomed's dedicated end-to-end validation system for LVAD development effectively solves all these bottlenecks.

Real-time P-V Loop Monitoring with Over 90% Clinical Consistency
Equipped with advanced real-time P-V loop plotting function, the system collects high-precision pressure and volume data, enabling researchers to visually evaluate how LVAD operation relieves cardiac load.
Over 90% consistency between simulated data and actual clinical outcomes
Optimized algorithms support repeated anti-suction logic verification in labs, greatly reducing reliance on time-consuming animal experiments
 
Simuheart Pulsatile Pump: Restore Authentic Human Hemodynamic Environment
Featuring high precision and wide applicability, our pulsatile pump, matched with vascular phantoms and fluid assemblies, accurately replicates core characteristics of human blood circulation and establishes realistic macroscopic hemodynamic environments consistent with in-vivo conditions. It enables accurate acquisition of stroke volume and other key data per cardiac cycle.
Full frequency adaptation: adjustable heart rate ranging from 1 to 200 bpm
Multi-specimen simulation: compatible with small animal experiments and adult clinical research with one integrated system
 
High-precision Data Output to Empower Reliable R&D
In the field of artificial heart research, even a 0.1% deviation may lead to critical safety risks.
8-channel synchronous monitoring: full-range data coverage from pump inlet/outlet to distal blood vessels without monitoring blind spots
Superior accuracy: flow accuracy ±2%, control accuracy within 0.5%, providing authoritative basic data for maglev Simuheart Pump optimization and hemolysis risk assessment
Visual flow field observation: customized transparent 3D printed vascular models allow intuitive viewing of blood flow direction and eddy current distribution

Trandomed: Your Reliable R&D Partner Beyond Testing Equipment
Prototype Design Stage: Rapidly obtain H-Q performance curves, identify design defects in advance and reduce revision costs.
Algorithm Development Stage: Simulate diverse extreme physiological conditions to cut down expensive animal experiment frequency.
Regulatory Application Stage: Generate 24-hour continuous stable operation reports. Compliant test data greatly speeds up NMPA and FDA approval procedures.
Devoted to medical device simulation technology, Trandomed delivers accurate validation solutions to safeguard every artificial heart research project.
If you are in search of high-efficiency LVAD test benches or in-vitro physiological circulation systems, feel free to contact us for further cooperation.

​